Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;8(1):20-30.
doi: 10.1007/s40495-021-00268-3. Epub 2021 Dec 2.

Biomarkers from Secondary Complications in Spinal Cord Injury

Hani Alostaz  1 , Li Cai  1
Affiliations

Biomarkers from Secondary Complications in Spinal Cord Injury

Hani Alostaz et al. Curr Pharmacol Rep. 2022 Feb.

Abstract

Purpose of review: In the USA, spinal cord injury (SCI) occurs in 40 people per million every year due to events such as car accidents, falls, violence, or sports injury. Secondary complications that arise from SCI are life-threatening and should be treated as early as possible. In some cases, it is not completely obvious what complication a patient may have until it is too late. Therefore, biomarkers are required to assess the levels of secondary complications after SCI. As there are several complications that pose different warning signs, different biomarkers may be beneficial in early detection, maintenance, and long-term care for patients with SCI.

Recent findings: Numerous studies have been conducted on biomarkers in various SCI and its related complications, such as neuropathic pain and deep vein thrombosis. In recent years, research has expanded with biomarkers discovered by cellular and molecular, genome-wide transcriptomic analysis, bioinformatics, and clinical studies. Biomarkers have allowed early prediction of the severity of secondary complications due to SCI.

Summary: In this review, we summarize recent studies on the common biomarkers for the secondary complications related to SCI. We highlight the reliable biomarkers that have been tested, e.g., sclerostin, NGF, D-dimer, oncostatin M (OSM), microbiota, and C-reactive protein, which are valuable and with clinical importance. This review also emphasizes continuing research in biomarkers as they can provide valuable cellular and molecular insight into secondary complications after SCI.

Keywords: Biomarkers; Secondary complications; Spinal cord injury.

PubMed Disclaimer

References

    1. Ahuja CS, Nori S, Tetreault L, Wilson J, Kwon B, Harrop J, et al. Traumatic spinal cord injury-repair and regeneration. Neurosurgery. 2017;80(3S):S9–22. 10.1093/neuros/nyw080. - DOI - PubMed
    1. Albayar AA, Roche A, Swiatkowski P, Antar S, Ouda N, Emara E, et al. Biomarkers in spinal cord injury: prognostic insights and future potentials. Front Neurol. 2019;10:27. 10.3389/fneur.2019.00027. - DOI - PMC - PubMed

    2. This article provides a review of traumatic spinal cord injury in terms of consequences and its long term outlook. This article also describes common complications of SCI as well.

    1. Leister I, Haider T, Mattiassich G, Kramer JLK, Linde LD, Pajalic A, et al. Biomarkers in traumatic spinal cord injurytechnical and clinical considerations: a systematic review. Neurorehabil Neural Repair. 2020;34(2):95–110. 10.1177/1545968319899920. - DOI - PubMed
    1. Wong KR, Mychasiuk R, O’Brien TJ, Shultz SR, McDonald SJ, Brady RD. Neurological heterotopic ossification: novel mechanisms, prognostic biomarkers and prophylactic therapies. Bone Res. 2020;8(1):42. 10.1038/s41413-020-00119-9. - DOI - PMC - PubMed

    2. This article discusses NHO as a complication in that it provides a background and multiple viable biomarkers. This article also provides a recommendation for a therapeutic target to decrease NHO.

    1. Alexander KA, Tseng HW, Fleming W, Jose B, Salga M, Kulina I, et al. Inhibition of JAK1/2 tyrosine kinases reduces neurogenic heterotopic ossification after spinal cord injury. Front Immunol. 2019;10:377. 10.3389/fimmu.2019.00377. - DOI - PMC - PubMed

    2. This article provides a detailed explanation of causes for NHO. The article also describes therapeutic targets that could be further studied in order to mitigate this particular complication.

LinkOut - more resources